Limitations, agreements, and source contact

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide · Source last updated 2025-06-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

rnt1@columbia.edu

organization

Columbia University

phone

(212) 305-4076

title

Robert Taub, MD, PhD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice